){kind=logo}
Loeb & Loeb LLP is proud to sponsor the American Conference Institute's 9th Annual Summit on Biosimilars taking place from June 25-27, 2018.
About the event:
Discuss the future of biosimilars and formulate solutions to the complex regulatory and patent challenges ahead with industry leaders from both innovator and biosimilar companies
Last year, as the Supreme Court issued its unanimous opinion in Sandoz v. Amgen, ACI had the distinct honor of having top leaders from the biologics industry in our Biosimilars conference room. As the news broke, our attendees had the unique opportunity to be the first to address the decision and potential implications in face-to-face conversations with their peers.
For more information, including how to register, please visit the event website.
About the event:
Discuss the future of biosimilars and formulate solutions to the complex regulatory and patent challenges ahead with industry leaders from both innovator and biosimilar companies
Last year, as the Supreme Court issued its unanimous opinion in Sandoz v. Amgen, ACI had the distinct honor of having top leaders from the biologics industry in our Biosimilars conference room. As the news broke, our attendees had the unique opportunity to be the first to address the decision and potential implications in face-to-face conversations with their peers.
For more information, including how to register, please visit the event website.